Vyome Holdings Inc. Completes Merger and Begins Trading on Nasdaq Under New Ticker "HIND
Vyome Holdings, Inc. has undergone a significant transition following the resignation of ReShape's Board of Directors and management team. The new Board and management team from Vyome have been installed, and the company has been successfully listed on the Nasdaq exchange. As part of this merger, ReShape has been renamed Vyome Holdings, Inc. $(VHI)$ and will now focus on advancing its immuno-inflammatory assets and exploring opportunities within the US-Indian innovation corridor. Additionally, the company announced the issuance of 376,256 common shares to consultants, advisors, and for terminating a share subscription agreement. Three put/call option agreements have also been established, including one involving the exchange of shares between Indian stockholders and VHI common stock.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vyome Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-082924), on September 02, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.